Antibodies against IGFR-like receptor and uses thereof
Grant
US12583928B2
Kind: B2
Mar 24, 2026
Assignee
Helmholtz Zentrum München—Deutsches Forschungszentrum für Gesundheit und Umwelt (GmbH)
Inventors
Heiko Lickert
Abstract
The present invention provides a novel IGFR-like receptor and antagonists and agonists for targeting said receptor. Said antagonists and agonists are envisaged for use as a medicament, and in particular for treatment of diabetes.
CPC Classifications
C07K 16/2863
C07K 16/065
C07K 2317/24
G01N 33/53
G01N 2800/042
A61K 2039/505
Filing Date
2022-02-24
Application No.
17679545
Claims
15